Beta Drugs Share Price
Small Cap | Pharmaceuticals and health care | NSE: BETA
₹1,781.65 
-58.35 (-3.17 %)
Last Updated: 09 Apr 2025 03:31 PM
BULLISH
Overview
Open (₹) 1,840.00
High (₹) 1,840.00
Low (₹) 1,730.00
Prev. Close (₹) 1,840.00
Volume 4,515
VWAP (₹) 1,647.24
ROCE (%) 30.43
Industry P/E 43.25
TTM P/E 41.77
P/B Ratio 10.90
Market Cap (₹) Cr.1,798.50
Dividend Yield (%)--
EPS (₹) 37.90
ROE23.19%
Sales Growth (%) 30.21
Profit Growth (%)18.62
Day Range
1,840.001,840.00
52 Week Range
1,047.202,214.35
Historical Returns
Returns (6M)
5.72 %
Returns (1Y)
43.39 %
Returns (3Y)
223.21 %
Returns (5Y)
3508.04 %
Returns (6M)
5.72 %
Returns (1Y)
43.39 %
Returns (3Y)
223.21 %
Returns (5Y)
3508.04 %
SWOT Analysis
- Company with (18.62%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Company with 18.62% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BULLISHRSI 47.81
MFI 16.45
ATR 89.58
Commodity Channel Index -87.21
ROC125 -0.83
ROC21 -16.86
Williams %R -79.52
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1,689.56 | 1,729.73 | 1,779.51 | 1,639.78 | 1,599.61 | 1,549.83 | 1,509.66 |
| Week Ago | 1,721.24 | 1,793.17 | 1,841.29 | 1,673.12 | 1,601.19 | 1,553.07 | 1,481.14 |
| Month Ago | 1,794.80 | 1,867.10 | 1,914.50 | 1,747.40 | 1,675.10 | 1,627.70 | 1,555.40 |
EMA & SMA
1781.65
Current Price
Bullish Moving Averages
12
Bearish Moving Averages
8
5 Day 1649.86
9 Day 1689.33
10 Day 1703.98
12 Day 1707.41
14 Day 1722.37
20 Day 1804.57
26 Day 1804.66
50 Day 1893.66
100 Day 1936.67
200 Day 1661.86
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| BATRA VIJAY KUMAR | bulk | Buy | 01 Sept, 2020 | ₹84.95 | 50,400 | NSE |
| ADESH VENTURES LLP | bulk | Sell | 24 Jul, 2020 | ₹95.52 | 1,08,000 | NSE |
| ONKAR SINGH | bulk | Buy | 24 Jul, 2020 | ₹96.03 | 87,200 | NSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 05 Feb, 2025 | Bonus issue of equity shares in the ratio of 1:20 of Rs. 10/-. | 26 Mar, 2025 | 26 Mar, 2025 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 08 Apr, 2025 | NSE India | Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 08 Apr, 2025 | NSE India | Beta Drugs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| 29 Mar, 2025 | NSE India | BETA DRUGS LIMITED has informed the Exchange about Closure of Trading Window |
| 29 Mar, 2025 | NSE India | Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 27 Mar, 2025 | NSE India | BETA DRUGS LIMITED has informed the Exchange regarding Allotment of Securities |
| 27 Mar, 2025 | NSE India | Beta Drugs Limited has informed the Exchange regarding Board meeting held on March 27, 2025-allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. |
| 19 Mar, 2025 | NSE India | Beta Drugs Limited has informed the Exchange regarding ''''the Board meeting to be held on 27th March, 2025 to interalia, transact the following business:To consider and approve the allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue.''. |
| 19 Mar, 2025 | NSE India | BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 27-Mar-2025 to consider Other business. |
| 19 Mar, 2025 | NSE India | Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publication-Record date for Bonus Shares |
| 18 Mar, 2025 | NSE India | Beta Drugs Limited has informed the Exchange that Record date for the purpose of Bonus is 26-Mar-2025. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Others | To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. | 21 Mar, 2025 | 27 Mar, 2025 |
| Issue of Bonus & Others | To consider other business matters. | 19 Feb, 2025 | 05 Feb, 2025 |
| Quarterly Results | -- | 05 Nov, 2024 | 06 Nov, 2024 |
| To consider Fund Raising | -- | 17 Oct, 2024 | 19 Oct, 2024 |
| Audited Results | -- | 16 May, 2024 | 14 May, 2024 |
| Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. | 31 Oct, 2023 | 07 Nov, 2023 |
| Audited Results | -- | 26 Apr, 2023 | 08 May, 2023 |
| Quarterly Results | -- | 24 Oct, 2022 | 27 Oct, 2022 |
| Audited Results | -- | 27 Apr, 2022 | 27 Apr, 2022 |
| Quarterly Results | -- | 21 Oct, 2021 | 25 Oct, 2021 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 66.73% | 66.73% | 66.71% | 66.71% | 66.68% |
| Foreign Institutions + | 1.15% | 0.32% | 0.29% | 0.29% | 0% |
| Domestic Institutions + | 0.16% | 0.02% | 0.04% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 31.96% | 32.92% | 32.96% | 33.01% | 33.32% |
| Others | 0% | 0.01% | 0% | 0% | 0% |
About Beta Drugs
Beta Drugs is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 197.62 Cr. and Equity Capital is Rs. 9.61 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
2015
Managing Director
Mr. Rahul Batra
NSE Symbol
BETA
Beta Drugs Management
| Name | Designation |
|---|---|
| Mr. Rahul Batra | Chairperson & Managing Director |
| Mr. Varun Batra | Joint Managing Director |
| Mrs. Seema Chopra | Whole Time Director |
| Mr. Balwant Singh | Whole Time Director |
| Mr. Manmohan Khanna | Independent Director |
| Mr. Ashutosh Shukla | Whole Time Director |
| Mr. Rohit Parti | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹3,96,418.12 | ₹1,652.20  ₹1,688.35(-2.14%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,42,985.36 | ₹5,386.15 ₹5,387.30(-0.02%) | ₹3,640.100 - ₹6,448.750 |
| Cipla | ₹1,14,326.28 | ₹1,415.60 ₹1,432.55(-1.18%) | ₹1,310.050 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,05,825.12 | ₹3,126.80 ₹3,246.60(-3.69%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹95,468.61 | ₹2,313.95 ₹2,347.50(-1.43%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Beta Drugs
What is the share price of Beta Drugs?
The share price of Beta Drugs on 09 Apr, 2025 is ₹ 1,781.65.
What is 52W high and 52W low share price of Beta Drugs?
The highest and lowest 52W share prices of Beta Drugs are ₹ 2214.350 and ₹ 1047.200
What is the market cap of Beta Drugs?
The market capitalization of Beta Drugs as of 09 Apr, 2025 is ₹ 1,798.50 Crores
What is the P/E ratio of Beta Drugs?
The current P/E ratio of Beta Drugs as of 09 Apr, 2025 is 43.25
What is the PB ratio of Beta Drugs?
The PB ratio of Beta Drugs as of 09 Apr, 2025 is 10.90
Top Gainers
₹36.24
₹30.20 (0.20%)
₹697.45
₹584.85 (0.19%)
₹36.52
₹30.44 (0.20%)
₹14.76
₹12.30 (0.20%)
Top Losers
₹0.84
₹0.95 (-0.12%)
₹4.85
₹5.38 (-0.10%)
₹1.51
₹1.74 (-0.13%)
₹316.80
₹360.00 (-0.12%)
Market Indices
Sensex
₹73,847.15
₹74,227.08 (-0.01%)